Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results

被引：0
|
作者：
Thomas Semrad
Afsaneh Barzi
Heinz-Josef Lenz
Irene M. Hutchins
Edward J. Kim
I-Yeh Gong
Michael Tanaka
Laurel Beckett
William Holland
Rebekah A. Burich
Leslie Snyder-Solis
Philip Mack
Primo N. Lara
机构：
[1] University of California Davis Comprehensive Cancer Center,Division of Hematology/Oncology, Department of Internal Medicine
[2] University of Southern California Norris Cancer Center,Medical Oncology, Keck School of Medicine
[3] University of California,Department of Internal Medicine
[4] Davis,Division of Biostatistics, Department of Public Health Sciences
[5] University of California,undefined
[6] Davis,undefined
来源：
International Journal of Clinical Oncology | 2015年 / 20卷
关键词：
Gemcitabine; Erlotinib; Pancreatic cancer; Pharmacodynamic separation; KRAS mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：518 / 524
页数：6
相关论文
共 50 条
  • [31] Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Mustafa Cengiz
    Faruk Zorlu
    Suayip Yalcin
    Murat Gurkaynak
    I. Lale Atahan
    Ibrahim H. Gullu
    Medical Oncology, 2007, 24 : 239 - 243
  • [32] Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
    Habermehl, Daniel
    Kessel, Kerstin
    Welzel, Thomas
    Hof, Holger
    Abdollahi, Amir
    Bergmann, Frank
    Rieken, Stefan
    Weitz, Juergen
    Werner, Jens
    Schirmacher, Peter
    Buechler, Markus W.
    Debus, Juergen
    Combs, Stephanie E.
    RADIATION ONCOLOGY, 2012, 7
  • [33] Concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer
    Cengiz, Mustafa
    Zorlu, Faruk
    Yalcin, Suayip
    Gurkaynak, Murat
    Atahan, I. Lale
    Gullu, Ibrahim H.
    MEDICAL ONCOLOGY, 2007, 24 (02) : 239 - 243
  • [34] Phase II study of gemcitabine in combination with cisplatin in patients with locally advanced and/or metastatic pancreatic cancer
    Brodowicz, T
    Wolfram, RM
    Köstler, WJ
    Tomek, S
    Vaclavik, I
    Steger, GG
    Teleky, B
    Függer, R
    Jakesz, R
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (08) : 623 - 628
  • [35] Combination Chemoherapy with S-1 and Gemcitabine for Locally Advanced and/or Metastatic Unresectable Pancreatic Cancer
    Takayama, Yukiko
    Shimizu, Kyoko
    Tahara, Junko
    Oyama, Hiroyasu
    Hayashi, Kazuhiko
    Shiratori, Keiko
    GASTROENTEROLOGY, 2009, 136 (05) : A314 - A314
  • [36] Phase II trial of combined regional hyperthermia and gemcitabine for locally advanced or metastatic pancreatic cancer
    Ishikawa, Takeshi
    Kokura, Satoshi
    Sakamoto, Naoyuki
    Ando, Takashi
    Imamoto, Eiko
    Hattori, Takeshi
    Oyamada, Hirokazu
    Yoshinami, Naomi
    Sakamoto, Masafumi
    Kitagawa, Kazutomo
    Okumura, Yoko
    Yoshida, Naohisa
    Kamada, Kazuhiro
    Katada, Kazuhiro
    Uchiyama, Kazuhiko
    Handa, Osamu
    Takagi, Tomohisa
    Yasuda, Hiroaki
    Sakagami, Junichi
    Konishi, Hideyuki
    Yagi, Nobuaki
    Naito, Yuji
    Yoshikawa, Toshikazu
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2012, 28 (07) : 597 - 604
  • [37] Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
    Yaman Suleiman
    Amit Mahipal
    David Shibata
    Erin M. Siegel
    Helen Jump
    William J. Fulp
    Gregory M. Springett
    Richard Kim
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 481 - 487
  • [38] A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
    Hong Suk Song
    Young Rok Do
    Heung Moon Chang
    Min Hee Ryu
    Kyung Hee Lee
    Yeul Hong Kim
    Dae Sik Hong
    Jae Yong Cho
    Kyoung Eun Lee
    Si Young Kim
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 763 - 768
  • [39] Bevacizumab plus gemcitabine for the neoadjuvant treatment of locally advanced non-metastatic pancreatic cancer
    Gnant, M.
    Schoppmann, S.
    Kuehrer, I
    Goetzinger, P.
    Sahora, K.
    Kandutsch, S.
    Wrba, F.
    Brostjan, C.
    Goetzinger, P.
    Turetschek, K.
    Zielinski, C.
    Teleky, B.
    Fried, J.
    Stift, A.
    Jakesz, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 70 - 71
  • [40] Use of Meriva as complementary therapy of locally advanced or metastatic pancreatic cancer (PC) with gemcitabine (GEM).
    Solda, Caterina
    Sperti, Cosimo
    Romeo, Bardini
    Da Dalt, Gianfranco
    Gion, Massimo
    Ursini, Fulvio
    Fiduccia, Pasquale
    Aliberti, Camillo
    Pastorelli, Davide
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345